USFDA nod to Roche Gazyva/Gazyvaro for lupus nephritis Ruchika Sharma22 Oct 2025 6:37 PM ISTBasel: Roche has announced that the US Food and Drug Administration (FDA) has approved Gazyva/Gazyvaro (obinutuzumab) for the treatment of adult...
Natco Gets SC Nod to Launch Generic Risdiplam at 80% Lower Price, Roche Appeal Dismissed Parthika Patel18 Oct 2025 7:14 PM ISTNew Delhi: The Supreme Court has given the go-ahead to Natco Pharma for launching its generic version of Risdiplam in India, dismissing the appeal...
Roche Moves SC Against Delhi HC Nod to Natco's Rs 15,900 Generic Risdiplam for Spinal Atrophy Parthika Patel16 Oct 2025 7:44 PM ISTNew Delhi: In a major escalation of the patent battle over a life-saving rare disease drug, Swiss pharmaceutical giant F. Hoffmann-La Roche AG has...
Roche gets USFDA clearance for Elecsys pTau181 test for Alzheimer's disease Ruchika Sharma15 Oct 2025 7:02 PM ISTIndianapolis: Roche has announced that the United States Food and Drug Administration (FDA) has cleared its Elecsys pTau181 test, the...
Delhi HC Dismisses Roche Appeal, Allows Natco to Continue Selling Generic Risdiplam for Spinal Muscular Atrophy Susmita Roy11 Oct 2025 9:41 PM ISTNew Delhi: The Delhi High Court has dismissed an appeal filed by Swiss drug major F. Hoffmann-La Roche AG and its Indian arm, challenging the order of...
Roche receives CE mark for AI based Kidney Klinrisk Algorithm Ruchika Sharma8 Oct 2025 10:00 AM ISTBasel: Roche, in collaboration with KlinRisk, Inc., has received the CE-mark for the AI-based risk stratification tool to assess progressive...
Roche bags USFDA nod for Tecentriq plus lurbinectedin for extensive-stage small cell lung cancer Ruchika Sharma3 Oct 2025 1:11 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Tecentriq (atezolizumab) and Tecentriq Hybreza...
Roche subcutaneous formulation of Lunsumio recommended by CHMP for EU nod for follicular lymphoma Ruchika Sharma21 Sept 2025 2:45 PM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of...
Roche to acquire 89bio for up to USD 3.5 billion Ruchika Sharma18 Sept 2025 11:30 AM ISTBasel: Roche has announced that it has entered into a definitive merger agreement to acquire 89bio, Inc., a publicly listed clinical-stage...
Roche receives EU CE mark for Contivue for neovascular age-related macular degeneration Ruchika Sharma7 Sept 2025 2:30 PM ISTBasel: Roche has announced that it has received the EU CE mark for its Port Delivery Platform containing Susvimo, which will now be known as...
No Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in India Parthika Patel6 Aug 2025 3:34 PM ISTNew Delhi: Roche Products (India) Pvt Ltd has been directed by the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation...
Roche Susvimo maintains vision over five years with two refills per year in people with nAMD Ruchika Sharma4 Aug 2025 12:30 PM ISTBasel: Roche has announced new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the...
